Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Letrozole × CNS × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 9 Gynecologic 3 Sarcoma 1 Genitourinary 1 Gastrointestinal 1 CNS 1

Conditions

Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 15 Temozolomide 14 Radiotherapy 9 fluciclovine F-18 6 Specimen Handling 6 Bevacizumab 6 fluorodopa F 18 4 Topotecan 4 Irinotecan 4 Fluorodeoxyglucose F18 4 Ferrosoferric Oxide 4 Biopsy 4 gallium Ga 68 dotatate 3 abemaciclib 3 Radiation 3 Pemetrexed 3 Methotrexate 3 Ketoconazole 3 Everolimus 3 Cyclophosphamide 3 posaconazole 2 poly ICLC 2 olaparib 2 niraparib 2 Vincristine 2 Tissue Array Analysis 2 Therapeutics 2 Surgical Procedures, Operative 2 Standard of Care 2 Rituximab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03122197 2023-12-13

Study of Letrozole in Recurrent Gliomas

University of Cincinnati

Phase EARLY_PHASE1 Unknown

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡